Fingerprint
Dive into the research topics of 'A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically